Health Discovery Corporation (HDVY)
OTC PINK OTC PINK Primary Summary
Health Discovery Corporation (HDVY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Health Discovery Corporation ever had a stock split?
Health Discovery Corporation Profile
| Health Care Technology Industry | Healthcare Sector | Alan K. Hauser CEO | OTC PINK Exchange | 42218R100 CUSIP |
| US Country | 3 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Health Discovery Corporation is a company based in Atlanta, Georgia, that specializes in the development of pattern recognition technologies. Founded in 2001, it focuses on using advanced mathematical techniques to analyze massive datasets to identify patterns. These technologies are mainly applied in the field of molecular diagnostics. Through its innovative approach, Health Discovery Corporation aims to uncover complex patterns that can lead to breakthroughs in the understanding and treatment of various diseases. Its operations primarily span the United States, where it leverages its intellectual property, including Support Vector Machines (SVM) and Fractal Genomic Modeling technology, to enhance molecular diagnostics.
Products and Services
- Support Vector Machines (SVM)
- Biomarkers Identification
- Fractal Genomic Modeling Technology
An advanced mathematical algorithm that is a cornerstone of Health Discovery Corporation's technology portfolio. SVM is used for pattern recognition and data classification. By analyzing vast amounts of data, SVM technology helps in identifying complex patterns and relationships that are not readily apparent, particularly in the diagnosis and understanding of various health conditions.
Health Discovery Corporation utilizes its technological capabilities to identify and validate biomarkers. These biomarkers serve as biological indicators or genetic expression signatures indicative of certain disease states. The identification of reliable biomarkers is crucial for the development of diagnostic tests and personalized medicine, as they can significantly improve the accuracy of disease diagnosis and the effectiveness of treatment strategies.
This technology involves the application of fractal analysis to genomic data. Fractal Genomic Modeling is used by Health Discovery Corporation to uncover patterns within genetic material that could indicate predisposition to certain diseases or the effectiveness of specific treatments. This cutting-edge approach offers a novel way of understanding the complex interplay between genetics and disease, paving the way for advancements in genomic medicine.
